Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Dyne Therapeutics, Inc. (DYN)  
$31.88 0.68 (2.18%) as of 4:30 Fri 5/31


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 81,110,000
Market Cap: 2.59(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.62 - $35.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 21.5
Insider 3/6 Months : 22.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Dyne Therapeutics is a muscle disease company focused on developing therapeutics for people living with genetically driven diseases. Co. is developing the following product candidates: DYNE-101, to address the genetic basis of myotonic dystrophy type 1 by targeting the toxic nuclear DMPK RNA that causes the disease; DYNE-251 for patients with mutations amenable to skipping Exon 51, to be followed by the development of therapeutics for patients with mutations amenable to skipping other exons, including Exon 53, 45 and 44; and DYNE-301 to address the genetic basis of facioscapulohumeral dystrophy by reducing DUX4 expression in muscle tissue.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,714,285 1,714,285 3,583,447
Total Buy Value $0 $29,999,988 $29,999,988 $50,000,022
Total People Bought 0 1 1 3
Total Buy Transactions 0 1 1 3
Total Shares Sold 733,732 5,067,912 5,495,480 5,751,795
Total Sell Value $19,312,085 $120,465,489 $125,810,009 $128,995,680
Total People Sold 6 9 9 9
Total Sell Transactions 23 77 99 109
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 229
  Page 10 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mcneill Jonathan See RemarksOfficer   •       –      –    2020-09-16 3 IO $0.00 $0 D/D 0 19,898     -
   Stehman-Breen Catherine Director   –       •      –    2020-09-16 3 IO $0.00 $0 D/D 0 104,988     -
   Rhodes Jason P Director   –       •       •   2020-09-16 3 IO $0.00 $0 I/I 0 2,110,404     -
   Subramanian Romesh Chief Scientific OfficerOffice   •       –       •   2020-09-16 3 IO $0.00 $0 D/D 0 524,940     -

  229 Records found
  Previous  10    
  Page 10 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed